Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - Consultant

Applied Pharmaceutical Innovation / Kevin Bosch, Consultant

Registration Information

Client name: Applied Pharmaceutical Innovation
Lobbyist name: Kevin Bosch, Consultant
Initial registration start date: 2020-09-01
Registration status: Inactive
Registration Number: 932314-367337

Associated Communications

Total Number of Communication Reports: 2

Monthly communication reports in the last 6 months: 0

Version 1 of 2 (2020-09-01 to 2021-02-01)

Version 1 of 2 (2020-09-01 to 2021-02-01)



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

Applied Pharmaceutical Innovation/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
Applied Pharmaceutical Innovation/ 2020-09-01 2021-09-29

Responsible Officer Change History

Applied Pharmaceutical Innovation

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)

All Monthly Communication Reports for Applied Pharmaceutical Innovation

Kevin Bosch, Hill+Knowlton Strategies (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-2 of 2

  • Applied Pharmaceutical Innovation
    Consultant: Kevin Bosch
    Designated Public Office Holders who participated in the communication:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    • Kim Godard, Director | Health Canada (HC)
    • Linsey Hollett, Director General | Health Canada (HC)

    Subject Matter of the communication: Economic Development, Health, Industry, Research and Development
    Communication date: 2021-02-09
    Posted date: 2021-02-09
    Communication number: 367337-494658 View associated registration
  • Applied Pharmaceutical Innovation
    Consultant: Kevin Bosch
    Designated Public Office Holders who participated in the communication:
    • Terry Duguid, Member of Parliament | House of Commons

    Subject Matter of the communication: Economic Development, Health, Industry, Research and Development
    Communication date: 2020-09-15
    Posted date: 2020-10-06
    Communication number: 367337-483371 View associated registration

Public offices held: Kevin Bosch


Date Modified: